Cancer Home > Cetuximab Average Treatment Length

Cetuximab (Erbitux®) is just one of the many treatments available for cancer. Specifically, it is approved for squamous cell carcinoma of the head and neck, and certain kinds of advanced cancer affecting the colon and rectum. The average length of treatment for cetuximab will depend on the condition being treated and how well you tolerate the drug, among other things.
For example, if you are receiving cetuximab in addition to radiation treatment for head and neck cancer, you will be given your first dose one week before starting radiation. Subsequent doses will be given so that the dose is complete one hour before radiation. Treatment will continue for the remainder of radiation therapy (normally six or seven weeks).
(Click Cetuximab Dosage to learn more about how long treatment can last, the things that will affect your dose, and how to ensure the drug's safety and effectiveness.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.